Liu Dong, Xiao Yan, Subramanian Romesh R, Okamoto Ei-Ichi, Wilcox Josiah N, Anderson Leonard, De Leon Hector
*Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA; and †The Winship Cancer Institute, Emory University School of Medicine, Atlanta GA.
J Cardiovasc Pharmacol. 2016 May;67(5):433-41. doi: 10.1097/FJC.0000000000000369.
Leukocyte infiltration of adventitial and perivascular tissues is an early event in the development of vascular remodeling after injury. We investigated whether Slit/Robo-an axonal chemorepellent system in vertebrate and invertebrate development-is activated during the inflammatory phase that follows endothelial denudation. Using the rat carotid artery model of angioplasty, we conducted a time course analysis of mRNAs encoding Slit ligands (Slit2 and Slit3) and Robo receptors (Robo1, Robo2, and Robo4), as well as proinflammatory cell adhesion molecule (CAM) genes. Adventitial inflammatory cells were counted in immunostained arterial sections. E-selectin, vascular CAM-1, and intercellular CAM-1 were upregulated 2-3 hours after injury, followed by infiltration of neutrophils and monocytes as evidenced by real-time polymerase chain reaction, in situ hybridization, and immunohistochemistry. Slit2, Slit3, and Robo genes exhibited no expression changes at 3 hours; however, they were markedly upregulated 1 day after angioplasty. Intercellular CAM-1 expression was reduced by 50%, and the number of adventitial neutrophils decreased by >75% 1 day after angioplasty. Slit2 has been shown to be a potent chemorepelent of leukocytes, endothelial cells, and smooth muscle cells. Thus, we decided to further investigate the localization of Slit2 in injured vessels. Immunohistochemical stainings revealed the presence of Slit2 within the vessel wall and in the perivascular vasa vasorum of naive and injured arteries. Double immunohistochemical analyses showed that infiltrating monocytes expressed Slit2 in the perivascular and adventitial tissues of injured arteries 1 and 3 days postangioplasty. In addition, recombinant full-length Slit2 and Slit2-N/1118, an N-terminal fragment of Slit2, inhibited stromal cell-derived factor 1-mediated migration of circulating rat peripheral blood mononuclear cells. In summary, adventitial activation of CAM genes and neutrophil infiltration preceded upregulation of Slit/Robo genes. Sli2 expression colocalized with infiltrating inflammatory cells in the adventitial layer. This temporospatial association suggests that leukocyte chemorepellent Slit2 may be involved in halting the adventitial accumulation of inflammatory cells in injured vessels.
外膜和血管周围组织的白细胞浸润是损伤后血管重塑发展过程中的早期事件。我们研究了脊椎动物和无脊椎动物发育过程中的轴突化学排斥系统Slit/Robo在血管内皮剥脱后的炎症阶段是否被激活。利用大鼠颈动脉血管成形术模型,我们对编码Slit配体(Slit2和Slit3)和Robo受体(Robo1、Robo2和Robo4)的mRNA以及促炎细胞黏附分子(CAM)基因进行了时间进程分析。在免疫染色的动脉切片中对外膜炎症细胞进行计数。损伤后2 - 3小时,E选择素、血管细胞黏附分子-1和细胞间黏附分子-1上调,随后通过实时聚合酶链反应、原位杂交和免疫组织化学证实中性粒细胞和单核细胞浸润。Slit2、Slit3和Robo基因在3小时时无表达变化;然而,血管成形术后1天它们显著上调。血管成形术后1天,细胞间黏附分子-1表达降低50%,外膜中性粒细胞数量减少>75%。Slit2已被证明是白细胞、内皮细胞和平滑肌细胞的有效化学排斥剂。因此,我们决定进一步研究Slit2在受损血管中的定位。免疫组织化学染色显示,在未损伤和损伤动脉的血管壁及血管周围血管中存在Slit2。双重免疫组织化学分析表明,血管成形术后1天和3天,浸润的单核细胞在受损动脉的血管周围和外膜组织中表达Slit2。此外,重组全长Slit2和Slit2-N/1118(Slit2的N端片段)抑制基质细胞衍生因子1介导的循环大鼠外周血单个核细胞迁移。总之,CAM基因的外膜激活和中性粒细胞浸润先于Slit/Robo基因的上调。Slit2表达与外膜层浸润的炎症细胞共定位。这种时空关联表明,白细胞化学排斥剂Slit2可能参与阻止炎症细胞在受损血管外膜的积聚。